Thumbnail Image
Publication

Efficacy and safety of telotristat ethyl (TE) in combination with lanreotide (LAN) in patients with a neuroendocrine tumour and carcinoid syndrome (CS) diarrhoea (CSD): meta-analysis of phase III double-blind placebo (PBO)-controlled TELESTAR and TELECAST studies

Horsch, D
; 
Garcia-Carbonero, R
; 
Valle, Juan W
; 
Perros, P
; 
Welin, S
; 
Keeber, L
; 
Houchard, A
; 
Lapuerta, P
Citations
Altmetric:
Abstract
Authors
Horsch, D
Garcia-Carbonero, R
Valle, Juan W
Perros, P
Welin, S
Keeber, L
Houchard, A
Lapuerta, P
Affiliation
Department of Gastroenterology/Endocrinology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany
Description
Date
2018
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 105.57 KB
Keywords
Type
Meetings and Proceedings
Citation
H�rsch D, Garcia-Carbonero R, Valle JW, Perros P, Welin S, Keeber L, et al. 1314P Efficacy and safety of telotristat ethyl (TE) in combination with lanreotide (LAN) in patients with a neuroendocrine tumour and carcinoid syndrome (CS) diarrhoea (CSD): Meta-analysis of phase III double-blind placebo (PBO)-controlled TELESTAR and TELECAST studies. Annals of Oncology. 2018;29(suppl_8).
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/621720
Embedded videos